Clinical Trial Update: KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

This clinical trial update describes Phase 1 testing of KSV01 Injection for relapsed/refractory B-cell acute lymphoblastic leukemia. Recruitment is ongoing at Z…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• KSV01 Injection

Snippet

Sponsor: Zhejiang University | Conditions: B-ALL | Phase 1 | Status: RECRUITING